Does amlodipine cause flatulence or a persistent urge to have a bowel movement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amlodipine and Gastrointestinal Side Effects

Amlodipine does not cause flatulence or persistent bowel movements as recognized side effects. The documented gastrointestinal effects are limited to nausea and constipation, not flatulence or increased bowel frequency.

Documented Gastrointestinal Side Effects

According to the FDA drug label, the gastrointestinal adverse reactions associated with amlodipine include 1:

  • Nausea: Occurs in 2.9% of patients (compared to 1.9% with placebo)
  • Constipation: Reported in <1% but >0.1% of patients
  • Abdominal pain: Occurs in 1.6% of patients (compared to 0.3% with placebo)
  • Flatulence: Listed as occurring in <1% but >0.1% of patients, but not as a prominent or dose-related effect

Notably absent from the side effect profile are diarrhea or persistent urge to defecate. 1

Primary Side Effects of Amlodipine

The most common adverse effects are cardiovascular and vasodilatory in nature, not gastrointestinal 2:

  • Peripheral edema: Most frequent side effect (10.8% at 10 mg dose, 3.0% at 5 mg dose) 1
  • Headache: Common non-dose-related effect 2, 3
  • Dizziness and flushing: Dose-related effects 1
  • Palpitations: Occurs in 4.5% at 10 mg dose 1

Clinical Context

If a patient reports flatulence or constant bowel movements while taking amlodipine, alternative explanations should be investigated 1, 4, 5:

  • These symptoms are not characteristic of amlodipine's pharmacologic profile
  • Consider other medications, dietary factors, or underlying gastrointestinal conditions
  • The drug has been evaluated in over 11,000 patients with well-characterized adverse effect profiles that do not include these symptoms 1

Amlodipine is generally well-tolerated with discontinuation rates of only 1.5% due to adverse reactions, similar to placebo 1, 4, 5. The gastrointestinal effects that do occur (nausea, constipation) are mild and infrequent 1, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amlodipine Dosing and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Amlodipine: a new calcium antagonist.

American journal of hospital pharmacy, 1994

Research

Amlodipine in the current management of hypertension.

Journal of clinical hypertension (Greenwich, Conn.), 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.